Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Vevorisertib trihydrochloride | 1416775-08-0 | 99.13% | 696.11 | 25 MG
Supplier: Medchemexpress LLC 25MGHY137458A
Vevorisertib trihydrochloride is a selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitor. It potently inhibits phosphorylation of AKT with Kd values of 1.2 nM for AKT1 and 8.6 nM for AKT1-E17K, and IC50 values of 0.55, 0.81, and 1.3 nM for AKT1, AKT2, and AKT3, respectively. This compound can be used for cancer research.
- Selective, allosteric, pan-AKT and AKT1-E17K mutant inhibitor
- Potently inhibits phosphorylation of AKT
- Used for cancer research
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?